Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study

Chenghao Zhao,* Zhanwang Xiang,* Mingan Li, Haofan Wang, Huan Liu, Huzheng Yan, Mingsheng Huang Department of Interventional Radiology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, People’s Republic of China*These authors contributed equally to...

Full description

Bibliographic Details
Main Authors: Zhao C, Xiang Z, Li M, Wang H, Liu H, Yan H, Huang M
Format: Article
Language:English
Published: Dove Medical Press 2023-07-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
atezolizumab plus bevacizumab
lenvatinib
transarterial chemoembolization
hepatocellular carcinoma
efficacy
Online Access:https://www.dovepress.com/transarterial-chemoembolization-combined-with-atezolizumab-plus-bevaci-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/transarterial-chemoembolization-combined-with-atezolizumab-plus-bevaci-peer-reviewed-fulltext-article-JHC

Similar Items